Dominican Republic vs Greece: Access to anti-retroviral drugs, male
Dominican Republic
68.0%
in 2024
Greece
68.0%
in 2024
Dominican Republic rank
73rd
Greece rank
73rd
Access to anti-retroviral drugs, male over time
- Dominican Republic
- Greece
How they compare
Dominican Republic currently reports 68.0% against 68.0% in Greece, a difference of 0.0%.
Across all 25 years both countries report, Greece has been ahead every year.
Dominican Republic ranks 73rd and Greece ranks 73rd of 141 countries.
Greece has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Dominican Republic | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.5% | 46.9% | 42.4% | Greece |
| 2010s | 30.8% | 61.1% | 30.3% | Greece |
| 2020s | 59.2% | 67.8% | 8.6% | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Dominican Republic or Greece?
- Dominican Republic, at 68.0% against 68.0% in Greece as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Dominican Republic and Greece?
- 0.0%, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Greece?
- 25 years are reported by both, from 2000 to 2024.
- How do Dominican Republic and Greece rank globally for access to anti-retroviral drugs, male?
- Dominican Republic ranks 73rd and Greece ranks 73rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.